Form 4: Kewaunee Scientific Corp Director John Russell Acquires Shares as Part of Compensation
SEC Form 4 Filing
Director John Russell acquired 1,896 shares of Kewaunee Scientific Corp common stock on May 7, 2025, as part of his annual compensation.
Summary
- On May 7, 2025, John Russell, a director of Kewaunee Scientific Corp, acquired 1,896 shares of common stock.
- The acquisition was part of his annual compensation under the company's 2023 Omnibus Incentive Plan.
- The shares were awarded at a price of $0.
- Following the transaction, Russell directly owns 34,396 shares of Kewaunee Scientific Corp.
- The transaction was reported on May 9, 2025.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a director's increased stake in the company through compensation, suggesting alignment with shareholder interests.
Positives
- The acquisition of shares by a director demonstrates confidence in the company.
- The equity portion of the compensation aligns the director's interests with those of the shareholders.
Industry Context
This is a routine disclosure related to insider transactions and executive compensation, common in publicly traded companies.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholders as it aligns the director's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 05/07/2025 | Date of transaction: John Russell acquired 1,896 shares of Kewaunee Scientific Corp common stock. |
| 05/09/2025 | Date of report filing. |
Keywords
Kewaunee Scientific Corp, Director, Share Acquisition, Compensation, Equity, Form 4, Russell, KEQU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.